openPR Logo
Press release

Prader-Willi Syndrome Drug Market Ongoing Trends and Recent Developments |Novo Nordisk A/S, Soleno Therapeutics, Inc, Levo Therapeutics, Ferring B.V, Zafgen, Inc,

02-04-2020 01:05 PM CET | Media & Telecommunications

Press release from: Data Bridge Market Research

Global Prader-Willi Syndrome Drug Market

Global Prader-Willi Syndrome Drug Market

Data Bridge Market Research announces the release of the report "Global Prader-Willi Syndrome Drug Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2026"

Global Prader-Willi syndrome drug market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing designations such as Fast track designation, Orphan drug designation for special drugs from regulatory bodies and development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.

Download Sample PDF Copy of Report  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prader-willi-syndrome-drug-market

Key Market Players:

The key market players in the global Prader-Willi syndrome drug market are Pfizer Inc, Novartis AG, Novo Nordisk A/S, Soleno Therapeutics, Inc, Levo Therapeutics, Ferring B.V, Zafgen, Inc, Chong Kun Dang pharmaceutical Corp, Saniona, Millendo Therapeutics, Inc, LG Corp, Insys Therapeutics, Inc, GeneScience Pharmaceuticals Co., Ltd, Rhythm Pharmaceuticals, Inc among others.

Key Developments in the Market

In July 2019, Soleno Therapeutics, Inc is developing Diazoxide Choline novel drug which is currently phase lll of clinical trial for the treatment of Prader-Willi syndrome. Diazoxide choline is a controlled release tablet which acts as potassium channel agonist to control appetite and increases the energy expenditure of body thus, limit the progression to morbid obesity and diabetes associated with Prader-Willi syndrome

In June 2019, Levo Therapeutics, Inc is developing intranasal Carbetocin(LV-101) novel drug which is currently under phase lll of clinical trial for the treatment of Prader-Willi syndrome. Carbetocin is a synthetic analogue of oxytocin that was specially designed to increase selectivity for the oxytocin receptor versus vasopressin receptors, providing a wider therapeutic window than oxytocin which will help in controlling the hyperphagia associated with Prader-Willi syndrome

Competitive Analysis:

Global Prader-Willi syndrome drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Prader-Willi syndrome drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers:

Increasing designations for special drugs from regulatory bodies is expected to drive the growth of the Prader-Willi syndrome market

Strong drug pipeline and number of clinical trials is continuously increasing for the treatment of Prader-Willi syndrome which is expected to drive the market growth

Increasing research and development initiatives and expenditure, is also expected to drive the market growth

Rising healthcare expenditures in developing countries can also act as a market driver

Market Restraints:

Low number of approved drugs for this disorder is restraining the market growth

Lack of awareness amongst people about Prader-Willi syndrome also acts as a restricting factor for this market growth

Individual's attitude, beliefs, including inadequate communication between clinicians and patients about PWS can hinder the market growth

Inquiry For Customize Report With Discount At https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prader-willi-syndrome-drug-market

Segmentation: Global Prader-Willi Syndrome Drug Market

By Types

Paternal Deletion

Maternal Uniparental Disomy(UPD)

Imprinting Defect

By Branded Drugs

Genotropin

Omnitrope

Norditropin

Others

By Diagnosis

Physical Examination

Genetic Testing

Blood Test

By Therapy

Hormonal Therapy

Physical therapy

Behavioral therapy

By Treatment

Medications

Dietary treatment

Human Growth Hormone replacement

Sex hormone Replacement

By Route of Administration

Oral

Subcutaneous

Intranasal

Others

By Distribution Channel

Direct

Online Pharmacy

Retailers

Others

By End-Users

Hospitals

Homecare

Specialty Clinics

By Geography

North America

Europe

Asia-Pacific

South America

Middle East & Africa

Get Full Toc @ https://www.databridgemarketresearch.com/toc/?dbmr=global-prader-willi-syndrome-drug-market

Reasons to Purchase this Report:

Current and future of global Prader-Willi syndrome drug market outlook in the developed and emerging markets.

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prader-Willi Syndrome Drug Market Ongoing Trends and Recent Developments |Novo Nordisk A/S, Soleno Therapeutics, Inc, Levo Therapeutics, Ferring B.V, Zafgen, Inc, here

News-ID: 1918538 • Views: …

More Releases from Data Bridge Market Research

Driving Innovation: Exploring the Automotive Digital Cockpit Market 2029
Driving Innovation: Exploring the Automotive Digital Cockpit Market 2029
The automotive industry is undergoing a significant transformation, with technology playing a pivotal role in shaping the future of vehicles. One of the most exciting developments is the rise of the automotive digital cockpit. This concept integrates various digital technologies into a cohesive user interface, enhancing the driving experience and providing a platform for advanced features. This guest post explores the overview of the automotive digital cockpit market, its scope,…
Navigating the Data Classification Market: Trends, Scope, and Growth Drivers 2028
Navigating the Data Classification Market: Trends, Scope, and Growth Drivers 202 …
In an era defined by digital transformation, effective data management has become crucial for organizations across all sectors. The need to categorize and manage vast amounts of data has given rise to the data classification market. This guest post explores the overview of the data classification market, its scope, current trends, and key factors driving growth. Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-data-classification-market The data classification market is expected to witness…
Document Management Software Technology Market 2030
Document Management Software Technology Market 2030
In today's fast-paced digital landscape, the importance of efficient document management cannot be overstated. Businesses across various sectors are increasingly recognizing the value of Document Management Software (DMS) technology to streamline their operations, enhance productivity, and ensure regulatory compliance. This guest post delves into the overview of the document management software market, its scope, emerging trends, and key factors driving its growth. Data Bridge Market Research analyses that the document management…
Ulnar-Mammary Syndrome Market to Observe Prominent by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Ulnar-Mammary Syndrome Market to Observe Prominent by 2029, Size, Share, Trends, …
Data Bridge Market Research analyses a growth rate in the ulnar-mammary syndrome market in the forecast period 2022-2029. Market Definition: Ulnar Mammary Syndrome is characterized with high variability, and typically with asymmetric presentation. The patients has defects of the postaxial components of the upper extremities which may include hypoplastic or missing ulna. In males, abnormalities such as delayed puberty and genital hypoplasia which leads to, cryptorchidism, and/or a shawl. This disease prevalence…

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals …
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…